Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry
Víctor Moreno‐Torres(Hospital Universitario Puerta de Hierro Majadahonda), Guillermo Ruiz‐Irastorza(BioCruces Health research Institute), Ángela Gutiérrez‐Rojas(Hospital Universitario Puerta de Hierro Majadahonda), Pablo Tutor‐Ureta(Hospital Universitario Puerta de Hierro Majadahonda), María Martínez‐Urbistondo(Hospital Universitario Puerta de Hierro Majadahonda), Raquel Castejón(Hospital Universitario Puerta de Hierro Majadahonda), Susana Mellor‐Pita, Carlos Tarín(Universidad San Pablo CEU), Ana Royuela(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Pedro Durán‐del Campo(Hospital Universitario Puerta de Hierro Majadahonda), Enrique Sánchez(Hospital Universitario Puerta de Hierro Majadahonda), Juan‐Antonio Vargas‐Núñez(Hospital Universitario Puerta de Hierro Majadahonda), Carmen de Mendoza
Cited by 10
Related Papers
Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues
|Journal of Clinical Medicine|2020|100
Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts
|Autoimmunity Reviews|2017|85
Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires
|Clinical Pharmacology & Therapeutics|2017|71
Red blood cell distribution width as prognostic factor in sepsis: A new use for a classical parameter
|Journal of Critical Care|2022|53
Bacterial infections in patients hospitalized with COVID-19
|Internal and Emergency Medicine|2021|49